How lung cancer cells change identity

by Mitchell S von Itzstein, Benjamin J Drapkin, John D Minna
Published 2021-08-01

Do mRNA profiles of lung adenocarcinomas provide information that will help individual patients?

by Mitchell S. von Itzstein, David E. Gerber, John D. Minna
Published 2020-10-01

Increased reporting but decreased mortality associated with adverse events in patients undergoing lung cancer surgery: Competing forces in an era of heightened focus on care qualit...

by Mitchell S von Itzstein, Arjun Gupta, Kemp H Kernstine, Kristin C Mara, Sahil Khanna, David E Gerber
Published 2020-01-01

Closing the gap: Contribution of surgical best practices to outcome differences between high‐ and low‐volume centers for lung cancer resection

by Mitchell S. vonItzstein, Rong Lu, Kemp H. Kernstine, Ethan A. Halm, Shidan Wang, Yang Xie, David E. Gerber
Published 2020-06-01

Association between body mass index, dosing strategy, and efficacy of immune checkpoint inhibitors

by Yang Xie, Vinita Popat, Shaheen Khan, Saad A Khan, Edward K Wakeland, Quan-Zhen Li, Murtaza Ahmed, Mitchell S von Itzstein, Thomas Sheffield, Farjana Fattah, Jason Y Park, Jessica M Saltarski, Yvonne Gloria-McCutchen, David Hsiehchen, Jared Ostmeyer, Nazima Sultana
Published 2021-06-01